Recurrent and founder mutations in the Netherlands: the cardiac phenotype of founder mutations p.S13F and p.N342D

Desmin-related myopathy (DRM) is an autosomally inherited skeletal and cardiac myopathy, mainly caused by dominant mutations in the desmin gene (). We describe new families carrying the p.S13F or p.N342D mutations, the cardiac phenotype of all carriers, and the founder effects. We collected the clinical details of all carriers of p.S13F or p.N342D. The founder effects were studied using genealogy and haplotype analysis. We identified three new index patients carrying the p.S13F mutation and two new families carrying the p.N342D mutation. In total, we summarised the clinical details of 39 p.S13... Mehr ...

Verfasser: Spaendonck-Zwarts, KY
van der Kooi, AJ
Lambregtse - van den Berg, Mijke
Ippel, EF
Boven, LG
Yee, WC
van den Wijngaard, A
Brusse, Esther
Hoogendijk, JE
Doevendans, PA
Visser, Martje
Jongbloed, JDH
Tintelen, JP
Dokumenttyp: Artikel
Erscheinungsdatum: 2012
Reihe/Periodikum: Spaendonck-Zwarts , KY , van der Kooi , AJ , Lambregtse - van den Berg , M , Ippel , EF , Boven , LG , Yee , WC , van den Wijngaard , A , Brusse , E , Hoogendijk , JE , Doevendans , PA , Visser , M , Jongbloed , JDH & Tintelen , JP 2012 , ' Recurrent and founder mutations in the Netherlands: the cardiac phenotype of founder mutations p.S13F and p.N342D ' , Netherlands Heart Journal , vol. 20 , no. 5 , pp. 219-228 . https://doi.org/10.1007/s12471-011-0233-y
Schlagwörter: /dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM044402 / name=EMC MM-04-44-02
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-29208194
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://pure.eur.nl/en/publications/efdf2cbf-8b3d-4fdb-9319-9d54ee5d5506

Desmin-related myopathy (DRM) is an autosomally inherited skeletal and cardiac myopathy, mainly caused by dominant mutations in the desmin gene (). We describe new families carrying the p.S13F or p.N342D mutations, the cardiac phenotype of all carriers, and the founder effects. We collected the clinical details of all carriers of p.S13F or p.N342D. The founder effects were studied using genealogy and haplotype analysis. We identified three new index patients carrying the p.S13F mutation and two new families carrying the p.N342D mutation. In total, we summarised the clinical details of 39 p.S13F carriers (eight index patients) and of 21 p.N342D carriers (three index patients). The cardiac phenotype of p.S13F carriers is fully penetrant and severe, characterised by cardiac conduction disease and cardiomyopathy, often with right ventricular involvement. Although muscle weakness is a prominent and presenting sympto DRM may occur as an apparently isolated cardiological disorder. The cardiac phenotypes of the founder mutations p.S13F and p.N342D are characterised by cardiac conduction disease and cardiomyopathy, often with right ventricular involvement.